Details for New Drug Application (NDA): 214493
✉ Email this page to a colleague
The generic ingredient in PIMAVANSERIN is pimavanserin tartrate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pimavanserin tartrate profile page.
Summary for 214493
Tradename: | PIMAVANSERIN |
Applicant: | Zydus |
Ingredient: | pimavanserin tartrate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 34MG BASE | ||||
Approval Date: | Jan 16, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription